58 related articles for article (PubMed ID: 9550487)
1. Arthralgias and cryoglobulinemia during protease inhibitor therapy in a patient infected with human immunodeficiency virus and hepatitis C virus.
Monsuez JJ; Vittecoq D; Musset L; Alemanni M; Dussaix E; Autran B
Arthritis Rheum; 1998 Apr; 41(4):740-3. PubMed ID: 9550487
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus.
Aaron L; Lebray P; Alyanakian MA; Roudière L; Therby A; Chaix ML; Dupont B; Pol S; Viard JP
Clin Infect Dis; 2005 Jan; 40(2):306-8. PubMed ID: 15655752
[TBL] [Abstract][Full Text] [Related]
3. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.
Bonnet F; Pineau JJ; Taupin JL; Feyler A; Bonarek M; de Witte S; Bernard N; Lacoste D; Morlat P; Beylot J
J Rheumatol; 2003 Sep; 30(9):2005-10. PubMed ID: 12966606
[TBL] [Abstract][Full Text] [Related]
5. Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.
Moore DM; Hogg RS; Braitstein P; Wood E; Yip B; Montaner JS
Antivir Ther; 2006; 11(1):125-9. PubMed ID: 16518968
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events.
Stebbing J; Waters L; Mandalia S; Bower M; Nelson M; Gazzard B
Clin Infect Dis; 2005 Sep; 41(6):906-11. PubMed ID: 16107994
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection.
Dezzutti CS; Astemborski J; Thomas DL; Marshall JH; Cabrera T; Purdy M; Vlahov D; Garfein RS
J Clin Virol; 2004 Nov; 31(3):210-4. PubMed ID: 15465414
[TBL] [Abstract][Full Text] [Related]
8. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
[TBL] [Abstract][Full Text] [Related]
9. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
[TBL] [Abstract][Full Text] [Related]
10. Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection.
Scotto G; Cibelli DC; Saracino A; Prato R; Palumbo E; Fazio V; Scarabaggio T; Monno L; Angarano G
J Infect; 2006 Apr; 52(4):294-9. PubMed ID: 16026843
[TBL] [Abstract][Full Text] [Related]
11. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
12. Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients.
Núñez M; Soriano V; López M; Ballesteros C; Cascajero A; González-Lahoz J; Benito JM
Clin Infect Dis; 2006 Nov; 43(9):1209-12. PubMed ID: 17029144
[TBL] [Abstract][Full Text] [Related]
13. The frequency, activation, and coreceptor expression of lymphocytes in human immunodeficiency virus/hepatitis C virus co-infected patients in China.
Shi W; Zhang Z; Zhang M; Liu J; Jiang Y; Wang Y; Jin X; Han X; Shang H
Jpn J Infect Dis; 2009 Jul; 62(4):284-8. PubMed ID: 19628906
[TBL] [Abstract][Full Text] [Related]
14. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
[TBL] [Abstract][Full Text] [Related]
15. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T lymphocytes and cryoglobulins in patients coinfected with HIV and hepatitis C virus: forgetting the hidden CD4+ cell subsets.
Perrella A; Atripaldi L; Sbreglia C; Borgia G; Sorrentino P; Tarantino G; Perrella O
Clin Infect Dis; 2005 Jun; 40(11):1707-8; author reply 1708-9. PubMed ID: 15889382
[No Abstract] [Full Text] [Related]
17. Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus.
Fabris P; Tositti G; Giordani MT; Romanò L; Betterle C; Pignattari E; Tagliaferri C; Muratori P; Manfrin V; de Lalla F
J Med Virol; 2003 Mar; 69(3):339-43. PubMed ID: 12526043
[TBL] [Abstract][Full Text] [Related]
18. Improvement in immune function due to treatment with indinavir despite severe immune deficiency.
Rothen M; Bisset LR; Joller-Jemelka HI; Grob P; Lüthy R; Opravil M
Antivir Ther; 1998; 3(3):159-67. PubMed ID: 10682133
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus.
Cooper CL; Parbhakar MA; Angel JB
Clin Infect Dis; 2002 May; 34(9):1259-63. PubMed ID: 11941553
[TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
Notermans DW; Pakker NG; Hamann D; Foudraine NA; Kauffmann RH; Meenhorst PL; Goudsmit J; Roos MT; Schellekens PT; Miedema F; Danner SA
J Infect Dis; 1999 Oct; 180(4):1050-6. PubMed ID: 10479130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
